410 related articles for article (PubMed ID: 29570794)
1. Understanding deregulated cellular and molecular dynamics in the haematopoietic stem cell niche to develop novel therapeutics for bone marrow fibrosis.
Gleitz HF; Kramann R; Schneider RK
J Pathol; 2018 Jun; 245(2):138-146. PubMed ID: 29570794
[TBL] [Abstract][Full Text] [Related]
2. The identification of fibrosis-driving myofibroblast precursors reveals new therapeutic avenues in myelofibrosis.
Kramann R; Schneider RK
Blood; 2018 May; 131(19):2111-2119. PubMed ID: 29572380
[TBL] [Abstract][Full Text] [Related]
3. Leptin-receptor-expressing bone marrow stromal cells are myofibroblasts in primary myelofibrosis.
Decker M; Martinez-Morentin L; Wang G; Lee Y; Liu Q; Leslie J; Ding L
Nat Cell Biol; 2017 Jun; 19(6):677-688. PubMed ID: 28481328
[TBL] [Abstract][Full Text] [Related]
4. Gli1
Schneider RK; Mullally A; Dugourd A; Peisker F; Hoogenboezem R; Van Strien PMH; Bindels EM; Heckl D; Büsche G; Fleck D; Müller-Newen G; Wongboonsin J; Ventura Ferreira M; Puelles VG; Saez-Rodriguez J; Ebert BL; Humphreys BD; Kramann R
Cell Stem Cell; 2017 Jun; 20(6):785-800.e8. PubMed ID: 28457748
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche.
Méndez-Ferrer S; Michurina TV; Ferraro F; Mazloom AR; Macarthur BD; Lira SA; Scadden DT; Ma'ayan A; Enikolopov GN; Frenette PS
Nature; 2010 Aug; 466(7308):829-34. PubMed ID: 20703299
[TBL] [Abstract][Full Text] [Related]
6. Still a burning question: the interplay between inflammation and fibrosis in myeloproliferative neoplasms.
Gleitz HFE; Benabid A; Schneider RK
Curr Opin Hematol; 2021 Sep; 28(5):364-371. PubMed ID: 34232140
[TBL] [Abstract][Full Text] [Related]
7. Identity of Gli1
Sena IFG; Prazeres PHDM; Santos GSP; Borges IT; Azevedo PO; Andreotti JP; Almeida VM; Paiva AE; Guerra DAP; Lousado L; Souto L; Mintz A; Birbrair A
Exp Hematol; 2017 Oct; 54():12-16. PubMed ID: 28690072
[TBL] [Abstract][Full Text] [Related]
8. Systematic dissection of coordinated stromal remodeling identifies Sox10
Sarkaria SM; Zhou J; Bao S; Zhao W; Fang Y; Que J; Bhagat G; Zhang C; Ding L
Cell Stem Cell; 2023 Jun; 30(6):832-850.e6. PubMed ID: 37267917
[TBL] [Abstract][Full Text] [Related]
9. Gremlin 1 depletion in vivo causes severe enteropathy and bone marrow failure.
Rowan SC; Jahns H; Mthunzi L; Piouceau L; Cornwell J; Doody R; Frohlich S; Callanan JJ; McLoughlin P
J Pathol; 2020 Jun; 251(2):117-122. PubMed ID: 32297672
[TBL] [Abstract][Full Text] [Related]
10. A conditionally immortalized Gli1-positive kidney mesenchymal cell line models myofibroblast transition.
Ó hAinmhire E; Wu H; Muto Y; Donnelly EL; Machado FG; Fan LX; Chang-Panesso M; Humphreys BD
Am J Physiol Renal Physiol; 2019 Jan; 316(1):F63-F75. PubMed ID: 30303712
[TBL] [Abstract][Full Text] [Related]
11. Neuropathy of haematopoietic stem cell niche is essential for myeloproliferative neoplasms.
Arranz L; Sánchez-Aguilera A; Martín-Pérez D; Isern J; Langa X; Tzankov A; Lundberg P; Muntión S; Tzeng YS; Lai DM; Schwaller J; Skoda RC; Méndez-Ferrer S
Nature; 2014 Aug; 512(7512):78-81. PubMed ID: 25043017
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal stem cells in myeloproliferative disorders - focus on primary myelofibrosis.
Selicean SE; Tomuleasa C; Grewal R; Almeida-Porada G; Berindan-Neagoe I
Leuk Lymphoma; 2019 Apr; 60(4):876-885. PubMed ID: 30277128
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of ALK5 inhibition in myelofibrosis.
Yue L; Bartenstein M; Zhao W; Ho WT; Han Y; Murdun C; Mailloux AW; Zhang L; Wang X; Budhathoki A; Pradhan K; Rapaport F; Wang H; Shao Z; Ren X; Steidl U; Levine RL; Zhao ZJ; Verma A; Epling-Burnette PK
JCI Insight; 2017 Apr; 2(7):e90932. PubMed ID: 28405618
[TBL] [Abstract][Full Text] [Related]
14. Migratory strategies of normal and malignant stem cells.
Hess DA; Allan AL
Methods Mol Biol; 2011; 750():25-44. PubMed ID: 21618081
[TBL] [Abstract][Full Text] [Related]
15. Perivascular Gli1+ progenitors are key contributors to injury-induced organ fibrosis.
Kramann R; Schneider RK; DiRocco DP; Machado F; Fleig S; Bondzie PA; Henderson JM; Ebert BL; Humphreys BD
Cell Stem Cell; 2015 Jan; 16(1):51-66. PubMed ID: 25465115
[TBL] [Abstract][Full Text] [Related]
16. [Pathomechanism and clinical impact of myelofibrosis in neoplastic diseases of the bone marrow].
Bedekovics J; Méhes G
Orv Hetil; 2014 Mar; 155(10):367-75. PubMed ID: 24583557
[TBL] [Abstract][Full Text] [Related]
17. Foxc1 is a critical regulator of haematopoietic stem/progenitor cell niche formation.
Omatsu Y; Seike M; Sugiyama T; Kume T; Nagasawa T
Nature; 2014 Apr; 508(7497):536-40. PubMed ID: 24590069
[TBL] [Abstract][Full Text] [Related]
18. Stromal SPARC contributes to the detrimental fibrotic changes associated with myeloproliferation whereas its deficiency favors myeloid cell expansion.
Tripodo C; Sangaletti S; Guarnotta C; Piccaluga PP; Cacciatore M; Giuliano M; Franco G; Chiodoni C; Sciandra M; Miotti S; Calvaruso G; Carè A; Florena AM; Scotlandi K; Orazi A; Pileri SA; Colombo MP
Blood; 2012 Oct; 120(17):3541-54. PubMed ID: 22955913
[TBL] [Abstract][Full Text] [Related]
19. SOHO State of the Art Updates and Next Questions: Myelofibrosis.
Pettit K; Verstovsek S; Talpaz M
Clin Lymphoma Myeloma Leuk; 2019 Apr; 19(4):191-199. PubMed ID: 30987952
[TBL] [Abstract][Full Text] [Related]
20. Gli1
Cassandras M; Wang C; Kathiriya J; Tsukui T; Matatia P; Matthay M; Wolters P; Molofsky A; Sheppard D; Chapman H; Peng T
Nat Cell Biol; 2020 Nov; 22(11):1295-1306. PubMed ID: 33046884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
